Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Topun Austin

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Pediatric Research|December 19, 2015
The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injuryAnne M Plomgaard, Wim van Oeveren, Tue H Petersen, et al.
Pediatric Research|July 8, 2016
Recommendations for neonatologist performed echocardiography in Europe: Consensus Statement endorsed by European Society for Paediatric Research (ESPR) and European Society for Neonatology (ESN)Willem P de Boode, Yogen Singh, Samir Gupta, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|December 10, 2015
The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readingsJoan Riera, Simon Hyttel-Sorensen, María Carmen Bravo, et al.
Neonatology|August 8, 2013
The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infantsAdelina Pellicer, Gorm Greisen, Manon Benders, et al.
Danish Medical Journal|January 24, 2013
Clinical use of cerebral oximetry in extremely preterm infants is feasibleSimon Hyttel-Sørensen, Topun Austin, Frank van Bel, et al.
Pediatric Research|December 19, 2023
Neuroprotective therapies in the NICU in preterm infants: present and future (Neonatal Neurocritical Care Series)Eleanor J Molloy, Mohamed El-Dib, Janet Soul, et al.
Trials|June 21, 2013
A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trialSimon Hyttel-Sorensen, Topun Austin, Frank van Bel, et al.
Pediatric Research|October 4, 2022
Neuroprotective therapies in the NICU in term infants: present and futureEleanor J Molloy, Mohamed El-Dib, Sandra E Juul, et al.
BMJ (Clinical Research Ed.)|January 9, 2015
Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trialSimon Hyttel-Sorensen, Adelina Pellicer, Thomas Alderliesten, et al.
Genome Medicine|December 12, 2018
Complex structural variants in Mendelian disorders: identification and breakpoint resolution using short- and long-read genome sequencingAlba Sanchis-Juan, Jonathan Stephens, Courtney E French, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Pediatric Research|December 19, 2015
The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injuryAnne M Plomgaard, Wim van Oeveren, Tue H Petersen, et al.
Pediatric Research|July 8, 2016
Recommendations for neonatologist performed echocardiography in Europe: Consensus Statement endorsed by European Society for Paediatric Research (ESPR) and European Society for Neonatology (ESN)Willem P de Boode, Yogen Singh, Samir Gupta, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|December 10, 2015
The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readingsJoan Riera, Simon Hyttel-Sorensen, María Carmen Bravo, et al.
Neonatology|August 8, 2013
The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infantsAdelina Pellicer, Gorm Greisen, Manon Benders, et al.
Danish Medical Journal|January 24, 2013
Clinical use of cerebral oximetry in extremely preterm infants is feasibleSimon Hyttel-Sørensen, Topun Austin, Frank van Bel, et al.
Pediatric Research|December 19, 2023
Neuroprotective therapies in the NICU in preterm infants: present and future (Neonatal Neurocritical Care Series)Eleanor J Molloy, Mohamed El-Dib, Janet Soul, et al.
Trials|June 21, 2013
A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trialSimon Hyttel-Sorensen, Topun Austin, Frank van Bel, et al.
Pediatric Research|October 4, 2022
Neuroprotective therapies in the NICU in term infants: present and futureEleanor J Molloy, Mohamed El-Dib, Sandra E Juul, et al.
BMJ (Clinical Research Ed.)|January 9, 2015
Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trialSimon Hyttel-Sorensen, Adelina Pellicer, Thomas Alderliesten, et al.
Genome Medicine|December 12, 2018
Complex structural variants in Mendelian disorders: identification and breakpoint resolution using short- and long-read genome sequencingAlba Sanchis-Juan, Jonathan Stephens, Courtney E French, et al.
Pageof 9